In Vitro Diagnostic Industry in China - Molecular Diagnosis Analyzers and Reagents XV

Gastric Cancer Detection Test

Gastric cancer is a common gastrointestinal carcinoid tumor, with the sixth highest incidence and second highest mortality rate among tumors. The recommended screening method in the Expert Consensus on Early Gastric Cancer Screening Process in China (Draft) is based on age, gender, serum gastrin-17 concentration, H. pylori antibody results, and pepsinogen ratio, giving a separate gastroscopy screening protocol by differentiating between high-, intermediate-, and low-risk groups. In 2020, when the screening program for gastric cancer based on molecular diagnostic methods was available, NMPA approved the Diagnostic Kit for RNF180/ Spetin9 Gene Methylation (Real Time PCR) (Registration No.: G.X.Z.Z 20203400447) of Biochain (Beijing) Science-Technology Inc. This product is designed for the in vitro qualitative detection of methylation RNF180 and Septin9 genes in human plasma. It is indicated for patients who have been diagnosed by a clinician and recommended for gastroscopy and who refuse to undergo gastroscopy for personal reasons.

Last: In Vitro Diagnostic Industry in China - Molecular Diagnosis Analyzers and Reagents XIV